Nora V V. Butta Coll

Head of Hemostasis laboratory
La Paz University Hospital

Presentation(s):

• PB0536 - Ex vivo study of the concomitant use of plasma-derived Factor VIII/Von Willebrand Factor and emicizumab in patients with severe Hemophilia A

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB1054 - Evaluation of platelet function in rare or undiagnosed bleeding disorders

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1172 - Impact of inhibitors on the procoagulant efficacy of bypass agents or hemostatic factors in combination with emicizumab

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1206 - Effect of agonists to thrombopoietin receptors on platelet glycome of patients with immune thrombocytopenia

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1208 - Discontinuation of thrombopoietin receptor agonists: a 10 year real-world experience from an academic hospital in Madrid

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1238 - Effect of constitutive activation of the calcium sensor STIM1 on haemostasis

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM